Medicinershoppen ApS: Financial statements 2025
CVR: 40600434
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Medicinershoppen ApS (CVR 40600434) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 518,176 and a net result of DKK 118,512 compared with DKK 158,971 the year before. That is a decrease of 24.8% compared with the year before. The profit margin was 22.9%. Equity in the 2025 report amounted to DKK 363,442. The solvency ratio was 100%.
- Revenue
- DKK 518,176
- Gross Profit
- DKK 156,737
- Profit/Loss
- DKK 118,512
- Equity
- DKK 363,442
- Total Assets
- DKK 363,502
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 518 t. | 157 t. | 119 t. | 363 t. | - |
| 2024 | 689 t. | 213 t. | 159 t. | 245 t. | - |
| 2023 | 496 t. | 138 t. | 92 t. | 244 t. | - |
| 2022 | 509 t. | 51 t. | 40 t. | 251 t. | - |
| 2021 | 569 t. | 220 t. | 171 t. | 211 t. | - |
Official annual report
How creditworthy is Medicinershoppen ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Medicinershoppen ApS has published its annual report for 2024. Revenue came to DKK 689,161, and the net result was DKK 158,971.
About Medicinershoppen ApS
Medicinershoppen ApS is a Danish company of the type Anpartsselskab based in Ribe, founded in 2019. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Martin Hollænder, Jacob Holmen Terkelsen and Kasper Bang Bredal. The company is owned by Martin Hollænder, Jacob Holmen Terkelsen and K. Bredal Invest ApS. In 2025, the company reported revenue of DKK 518,176 and a net result of DKK 118,512 compared with DKK 158,971 the year before. Equity in the 2025 report amounted to DKK 363,442.